Lost in the technical debate over drug prices is a struggle to afford medications happening across the country.
prescription drugs
Posted inPolitics
Kathleen Rice’s Questionable Rationale for Voting Down Drug Pricing Reform
She says she voted against the measure because the reconciliation bill won’t become law.
Posted inPolitics
How Kathleen Rice Is Threatening the Biden Agenda
Rice and two other House Democrats oppose aggressive drug price reform, which provides the budget savings available to fuel spending in the Build Back Better Act.
Posted inHealth and Social Policy
House, Senate Spar Over Reducing Drug Prices
There’s overwhelming support among Democrats for finally allowing Medicare to negotiate with drug companies. But the details matter.
Posted inLaw and Justice
How Do You Solve a Problem Like the Sacklers?
Judges have grown accustomed to issuing get-out-of-litigation cards to corporate looters in bankruptcy court.
Posted inHealth and Social Policy
How Biden Can Reinvent Big Pharma
So it can’t buy off competitors to keep prices high
Posted inHealth and Social Policy
Biden Executive Order Could Finally Lower Drug Prices
Several tools could lower prices directly—and serve as an indirect incentive to get Congress to act.
Posted inMoney, Politics, and Power
Pharma Companies Spend Billions More on Stock Buybacks Than Developing Drugs
House Oversight Committee report combats industry claims that lower drug prices would stifle innovation.
Posted inDay One Agenda
Unleash the Existing Anti-Monopoly Arsenal
Corporate power can be neutralized if federal agencies simply used the prodigious authority they’ve been granted.
Posted inHealth and Social Policy
The Post-COVID Health Care System Is Out of Control
After gouging Americans for record pandemic profits, the health care industry sets its sights on even more.